Skip to main content
News Icon

News categories: Honors & Funding

Collaborative research center being renewed

German Research Foundation funds CRC "Synaptic Micronetworks in Health and Disease" for another four years

The mammalian brain is extraordinarily complex - it is estimated to consist of around 100 billion nerve cells. Each of these cells is linked via synapses to tens of thousands of other brain cells. How do the elements of such a complex network work together to produce behavior? How do the networks change as a result of disease? For eight years, scientists have been investigating these and other questions in the Collaborative Research Center (CRC) 1089 "Synaptic Micronetworks in Health and Disease" at the University of Bonn. With great success: The German Research Foundation (DFG) is funding the interdisciplinary network for another four years. The requested funding amount is around 11.1 million euros. Partners are the caesar research center in the Max Planck Society and the German Center for Neurodegenerative Diseases in Bonn. Member of the Cluster of Excellence ImmunoSensation2 Prof. Heinz Beck is spokesperson of the recently renewed CRC.

At the most elementary level, the researchers want to investigate the properties of individual synapses - the contact points between nerve cells. They also want to investigate how these connections between brain cells are affected by diseases in their structure and function. At the next level up, the scientists want to find out how the many tens of thousands of synaptic input signals that arrive at cell processes of the nerve cells, so-called dendrites, are processed. Here, too, the focus is on epilepsy and Alzheimer's disease. At the level of neuronal networks, the researchers are interested in understanding the interplay between different types of nerve cells in the development of normal and pathologically disturbed behavior. To achieve these goals, mathematical and theoretical methods will be increasingly applied in the third funding period.

The researchers in the interdisciplinary CRC 1089 aim to make a significant contribution to a better understanding of how the brain works. However, a particular goal is also to investigate brain dysfunction in two of the most common neurological diseases: Epilepsy and Alzheimer's disease. The speaker of the Collaborative Research Center is the neuroscientist Prof. Dr. Heinz Beck, head of the Institute for Experimental Epileptology and Cognition Research at the University and the University Hospital of Bonn and a member of the ImmunoSensation2 Cluster of Excellence. Vice speaker is the biochemist Prof. Dr. Susanne Schoch McGovern from the Institute of Neuropathology at the University of Bonn.


Contact

Prof. Dr. Heinz Beck

Institute for Experimental Epileptology and Cognitive Research

University of Bonn

University Hospital Bonn

Phone: +49 228 6885270

Email: Heinz.Beck@ukb.uni-bonn.de

Prof. Dr. Susanne Schoch McGovern

Institute of Neuropathology, University of Bonn

University Hospital Bonn

Phone: +49 228 28719109

Email: susanne.schoch@uni-bonn.de

Related news

News Icon

News categories: Honors & Funding

Otto-Westphal Thesis Prize for Jonas Schulte-Schrepping

The German Society for Immunology e.V. (DGfI) anually honours one of its members by awarding the Otto-Westphal Thesis Prize. This year, Jonas Schulte-Schrepping from the research group of Prof. Joachim Schultze at the DZNE was selected for his PhD thesis on the systemic immune response to COVID-19. The prize is endowed with a prize money of 1,500 EUR.
View entry
DGORH Honours

News categories: Honors & Funding

Honours for research orthopaedic rheumatology

The German Society for Orthopaedic Rheumatology (DGORh) awards the Arthur Vick Prize annually. The award serves to promote research in the field of orthopaedic rheumatology. The prize is endowed with 7,000 euros.
View entry
News Icon

News categories: Honors & Funding

Acute lymphoblastic leukemia in children

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and poses a significant threat to health. The joint research project "EDI-4-ALL" (Early detection and interception for acute lymphoblastic leukemia) aims at the development of new analysis tools for the early detection of a genetic predisposition to ALL in newborns. The project is a joint endeavour by leading scientists from the Universities of Düsseldorf, Gießen and Bonn, the Charité Berlin and Zytovision, under participation of Prof. Alksandra Pandyra. The project is funded with a total of 2.6 million Euros by the BMBF.
View entry

Back to the news overview